- TheStreet.com•11 hours ago
The drugmaker is down nearly 46% year to date, which has created a great buying opportunity.
In my years of trading and investing, I've always found that the headlines can lead you to a few good opportunities, but the best stocks to buy are those that are underappreciated and underloved, and whose stories mostly go untold. As a result, many prime sellers of bad accounts stopped selling for fear they would get caught in some kind of regulatory nightmare.
- Barrons.com•2 days ago
Teva Pharmaceuticals (TEVA) took a beating Tuesday on news of its CEO’s departure. However CFRA’s Jeffrey Loo thinks the shares have fallen too far. Today Loo upgraded the shares from Hold to Buy, with ...
TEVA.TA : Summary for TEVA - Yahoo Finance
Teva Pharmaceutical Industries Limited (TEVA.TA)
Tel Aviv - Tel Aviv Delayed Price. Currency in ILS
Add to watchlist
|Bid||13,490.00 x 200|
|Ask||13,500.00 x 34100|
|Day's Range||13,230.00 - 13,600.00|
|52 Week Range||131.60 - 13,600.00|
|PE Ratio (TTM)||7,847.59|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|